| Mr Nick Jonathan Tapie, LMFT | |
|
1217 E South 11th St Ste A, Abilene, TX 79602-4252 | |
| (325) 518-0854 | |
| Not Available |
| Full Name | Mr Nick Jonathan Tapie |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 1217 E South 11th St Ste A, Abilene, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043519143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 201104 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Nick Jonathan Tapie, LMFT 1217 E South 11th St Ste A, Abilene, TX 79602-4252 Ph: (325) 518-0854 | Mr Nick Jonathan Tapie, LMFT 1217 E South 11th St Ste A, Abilene, TX 79602-4252 Ph: (325) 518-0854 |
News Archive
With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.
NovImmune, an antibody-focused research and development biotech company, announced today that it successfully entered into an exclusive licensing agreement with Genentech Inc. a member of the Roche Group for a proprietary anti-IL-17 fully human monoclonal antibody, and access to back-up antibodies.
Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.
Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty and throughout life.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.
› Verified 7 days ago
Sydney Morgan Reed, LMFT-ASSOCIATE Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 542 Hickory St Ste 201, Abilene, TX 79601 Phone: 801-837-1713 | |
Mr. Jonathan Nelson Cogburn, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1938 Mimosa Dr, Abilene, TX 79603 Phone: 325-200-7404 | |
Rachel Alyssa Lopez De Castilla Wooden, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 857 Flat Water Dr, Abilene, TX 79602 Phone: 210-452-7626 | |
Kyle Passmore, MMFT, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 500 Chestnut St Ste 1001, Abilene, TX 79602 Phone: 325-437-1001 | |
Mr. James Greer, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1502 North First Street, Abilene, TX 79601 Phone: 325-672-9999 Fax: 325-672-5237 | |
Zachary Miller, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4150 Southwest Dr Ste 218, Abilene, TX 79606 Phone: 325-692-4048 |